Manufacturers of drugs and medical devices regularly deploy digital tactics to communicate to their markets. However, promotional review committees, marketers, medical and regulatory personnel, and their attorney advisors must navigate the pitfalls of messaging in this heavily regulated space. This book addresses the complexities of reviewing digital tactics to ensure their compliance with FDA regulations and offers practical insight for effective promotion and review strategies.